Kate Sheridan is a general assignment reporter at STAT, covering biotech startups and the venture capital firms that back them. Prior to joining STAT in 2018, she was a science writer at Newsweek and completed internships at STAT and the Montreal Gazette. Kate graduated from McGill University with a bachelor’s degree in cognitive science in 2014. Currently based in New York, she prefers Montreal’s bagels. To send encrypted messages, please contact her on a non-work device via Signal at 617-475-0364.
